Latest Research And Development News

Page 61 of 63
Syntara Limited reported a robust $11.35 million increase in cash during the December 2024 quarter, underpinned by government grants and steady operational inflows. The company closes the period with a strong cash position of $18.07 million, signaling financial resilience.
Sophie Babbage
Sophie Babbage
29 Jan 2025
Noxopharm’s December 2024 quarterly report reveals expanding global interest in its Sofra technology through new Material Transfer Agreements and a strengthened cash position following a significant R&D tax rebate.
Ada Torres
Ada Torres
29 Jan 2025
Mighty Kingdom Ltd has received $1.809 million in tax rebates, significantly enhancing its capital flexibility as it refines operations and explores future growth opportunities.
Sophie Babbage
Sophie Babbage
28 Jan 2025
Nuix projects solid growth in Annualised Contract Value and revenue for the first half of FY25, despite elongated procurement timelines and increased contract complexity.
Victor Sage
Victor Sage
28 Jan 2025
Dropsuite Limited posted a standout quarter with a 37% rise in annual recurring revenue and a 42% jump in paid users, underscoring the strength of its partner ecosystem and product innovation.
Sophie Babbage
Sophie Babbage
28 Jan 2025
EBR Systems has signed a long-term lease for a 51,000 sq ft facility in Santa Clara, California, positioning itself for significant manufacturing expansion and future growth in wireless cardiac pacing technology.
Ada Torres
Ada Torres
28 Jan 2025
Butn Limited reported a modest net cash increase from operating activities in the December 2024 quarter, ending with a strong cash balance of $16.8 million. The fintech company’s latest cash flow report reveals ongoing investment and notable payments to related parties.
Claire Turing
Claire Turing
28 Jan 2025
Phoslock Environmental Technologies reported a widening cashflow deficit and disappointing sales in the December 2024 quarter, while legal challenges and share suspension continue to cloud its outlook.
Maxwell Dee
Maxwell Dee
24 Jan 2025
Alterity Therapeutics is poised to release topline data from its pivotal ATH434-201 Phase 2 trial in early-stage Multiple System Atrophy by February 2025, while managing a cash balance of A$4.54 million amid ongoing research expenses.
Ada Torres
Ada Torres
24 Jan 2025
Amcor plc has taken a pivotal step in its proposed merger with Berry Global by filing the definitive joint proxy statement with the SEC, setting the stage for shareholder votes in February. Integration planning is well underway as both companies prepare to unite their packaging expertise.
Victor Sage
Victor Sage
24 Jan 2025
Adisyn Ltd has successfully raised $10 million through a heavily oversubscribed placement, signaling strong institutional confidence in its graphene-enhanced semiconductor technology. The capital will accelerate development, commercial partnerships, and operational scaling.
Sophie Babbage
Sophie Babbage
24 Jan 2025
Galilee Energy reports a $1.9 million R&D tax refund and terminates its merger with Vintage Energy, while maintaining steady progress at its Glenaras Gas Project and a robust cash position of $4.38 million.
Maxwell Dee
Maxwell Dee
24 Jan 2025